Literature DB >> 1453429

Intestinal pseudo-obstruction in myotonic dystrophy.

H G Brunner1, B C Hamel, P Rieu, C J Höweler, F T Peters.   

Abstract

We describe four myotonic dystrophy (DM) patients who developed recurrent intestinal pseudo-obstruction. Some episodes were associated with gastroenteritis, while abdominal crowding may have occurred in one case during the third trimester of pregnancy. In most instances, however, no apparent cause could be identified. Intestinal pseudo-obstruction may occur at any stage of DM. In one of our cases intestinal pseudo-obstruction preceded significant muscle weakness by 15 years. Intestinal pseudo-obstruction is usually treated effectively with conservative measures. These include restriction of oral intake, intravenous fluids, and multiple enemas or colonoscopy. Improved intestinal function was noted in one case treated with the prokinetic agent cisapride. A partial sigmoid resection was performed in three cases with dolichomegacolon. No abnormalities were reported on histological examination. Since intestinal pseudo-obstruction is a rare complication of DM, it is of interest that two of our cases are sibs. Review of published reports showed several reports of familial occurrence of specific complications. These include cardiac conduction disturbances, focal myocarditis, mitral valve prolapse, pilomatrixomas, polyneuropathy, normal pressure hydrocephalus, and dilatation of the urinary tract. Myotonic dystrophy may show a tendency to familial clustering of organ specific involvement.

Entities:  

Mesh:

Year:  1992        PMID: 1453429      PMCID: PMC1016174          DOI: 10.1136/jmg.29.11.791

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  26 in total

1.  UNUSUAL MANIFESTATIONS DUE TO INVOLVEMENT OF INVOLUNTARY MUSCLE IN DYSTROPHIA MYOTONICA.

Authors:  N N KOHN; J S FAIRES; T RODMAN
Journal:  N Engl J Med       Date:  1964-12-03       Impact factor: 91.245

2.  Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease.

Authors:  J M Cobben; M H Breuning; C Schoots; L P ten Kate; K Zerres
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

3.  Familial mitral valve prolapse and myotonic dystrophy.

Authors:  S J Winters; B Schreiner; R C Griggs; P Rowley; N C Nanda
Journal:  Ann Intern Med       Date:  1976-07       Impact factor: 25.391

4.  Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus.

Authors:  E K Silverman; M A Province; E J Campbell; J A Pierce; D C Rao
Journal:  Hum Hered       Date:  1990       Impact factor: 0.444

5.  [Myotonic dystrophy (urological features and histochemical findings in muscle) (author's transl)].

Authors:  H D Bundschu; W Hauger; H D Lang
Journal:  Dtsch Med Wochenschr       Date:  1975-06-13       Impact factor: 0.628

6.  Smooth muscle involvement in congenital myotonic dystrophy.

Authors:  H G Lenard; H H Goebel; W Weigel
Journal:  Neuropadiatrie       Date:  1977-02

7.  Genetic linkage with chromosome 19 but not chromosome 17 in a family with myotonic dystrophy associated with hereditary motor and sensory neuropathy.

Authors:  H G Brunner; F Spaans; H J Smeets; M Coerwinkel-Driessen; T Hulsebos; B Wieringa; H H Ropers
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

8.  Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy.

Authors:  A H Beggs; P E Neumann; K Arahata; E Arikawa; I Nonaka; M S Anderson; L M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

9.  Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis.

Authors:  G Santis; L Osborne; R A Knight; M E Hodson
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

10.  Optic atrophy in Leber hereditary optic neuroretinopathy is probably determined by an X-chromosomal gene closely linked to DXS7.

Authors:  J Vilkki; J Ott; M L Savontaus; P Aula; E K Nikoskelainen
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

View more
  8 in total

Review 1.  Gastrointestinal manifestations in myotonic muscular dystrophy.

Authors:  Massimo Bellini; Sonia Biagi; Cristina Stasi; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Santino Marchi
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

2.  Intestinal non-rotation and pseudoobstruction in myotonic dystrophy: case report and review of the literature.

Authors:  C Sartoretti; S Sartoretti; D DeLorenzi; P Buchmann
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

Review 3.  Neurology and the gastrointestinal system.

Authors:  G D Perkin; I Murray-Lyon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

Review 4.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

5.  Myotonic Dystrophy Type 1 Complicated by Colonic Obstruction Due to a Bezoar.

Authors:  Aaron de Souza; Sanjeev Gupta
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

6.  Sigmoid Volvulus in Myotonic Dystrophy Type I (Steinert Disease).

Authors:  Ahmed B Bayoumy; Jennifer Suzanne Gjertsen; Maarten E Tushuizen
Journal:  Case Rep Gastroenterol       Date:  2022-03-31

7.  Male hypogonadism in myotonic dystrophy is related to (CTG)n triplet mutation.

Authors:  I Mastrogiacomo; E Pagani; G Novelli; C Angelini; M Gennarelli; E Menegazzo; G Bonanni; B Dallapiccola
Journal:  J Endocrinol Invest       Date:  1994-05       Impact factor: 4.256

Review 8.  Core Clinical Phenotypes in Myotonic Dystrophies.

Authors:  Stephan Wenninger; Federica Montagnese; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.